Back
Halozyme Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36
HALO
Halozyme Therapeutics, Inc.
Last Price:
$63.57
Seasonality Move:
2.35%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.
Halozyme Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.3 | Sell |
| 20-day SMA: | 71.46 | Sell |
| 50-day SMA: | 72.35 | Sell |
| 200-day SMA: | 66.57 | Sell |
| 8-day EMA: | 68.25 | Sell |
| 20-day EMA: | 70.35 | Sell |
| 50-day EMA: | 71.2 | Sell |
| 200-day EMA: | 67.18 | Sell |
Halozyme Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.76 | Sell |
| Relative Strength Index (14 RSI): | 34.35 | Sell |
| Chaikin Money Flow: | -1048539 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (68.11 - 78.09) | Sell |
| Bollinger Bands (100): | (65.45 - 74.09) | Sell |
Halozyme Therapeutics, Inc. Technical Analysis
| Feb 26 | Feb 27 | Mar 2 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 9 | Mar 10 | Mar 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | Mar | |||||||||
| 26 | 27 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Halozyme Therapeutics, Inc. Stock
Is Halozyme Therapeutics, Inc. Stock a Buy?
-
Halozyme Therapeutics, Inc. share price is 66.48 while HALO 8-day simple moving average is 68.30, which is a Sell signal.
-
The stock price of HALO is 66.48 while Halozyme Therapeutics, Inc. 20-day SMA is 71.46, which makes it a Sell.
-
Halozyme Therapeutics, Inc. 50-day simple moving average is 72.35 while HALO share price is 66.48, making it a Sell technically.
-
HALO stock price is 66.48 and Halozyme Therapeutics, Inc. 200-day simple moving average is 66.57, creating a Sell signal.
HALO Technical Analysis vs Fundamental Analysis
Sell
36
Halozyme Therapeutics, Inc. (HALO)
is a Sell
Is Halozyme Therapeutics, Inc. a Buy or a Sell?
-
Halozyme Therapeutics, Inc. stock is rated a SellThe current Halozyme Therapeutics, Inc. [HALO] share price is $66.48. The Score for HALO is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Halozyme Therapeutics, Inc. Stock Info
Market Cap:
7.8B
Price in USD:
66.48
Share Volume:
1.5M
Halozyme Therapeutics, Inc. 52-Week Range
52-Week High:
82.22
52-Week Low:
47.50
Sell
36
Halozyme Therapeutics, Inc. (HALO)
is a Sell
Halozyme Therapeutics, Inc. Share Price Forecast
-
What is the Halozyme Therapeutics, Inc. stock price today?The Halozyme Therapeutics, Inc. stock price is 66.48 USD today.
-
Will HALO stock go up or go down?Halozyme Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Halozyme Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Halozyme Therapeutics, Inc. is overvalued.
Is Halozyme Therapeutics, Inc. Stock a Buy?
-
Halozyme Therapeutics, Inc. share price is 66.48 while HALO 8-day exponential moving average is 68.25, which is a Sell signal.
-
The stock price of HALO is 66.48 while Halozyme Therapeutics, Inc. 20-day EMA is 70.35, which makes it a Sell.
-
Halozyme Therapeutics, Inc. 50-day exponential moving average is 71.20 while HALO share price is 66.48, making it a Sell technically.
-
HALO stock price is 66.48 and Halozyme Therapeutics, Inc. 200-day simple moving average is 67.18, creating a Sell signal.
Fundamental Analysis of Halozyme Therapeutics, Inc.
Is Halozyme Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.55 per share, an increase next quarter of $0.02 per share, an increase this year of $1.46 per share, and an increase next year of $1.83 per share.
Technical Analysis of Halozyme Therapeutics, Inc.
Should I short Halozyme Therapeutics, Inc. stock?
-
HALO Moving Average Covergence Divergence (MACD) indicator is -1.76, suggesting Halozyme Therapeutics, Inc. is a Sell
-
Halozyme Therapeutics, Inc. Relative Strength Index (RSI) is 34.35, which suggest Halozyme Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Halozyme Therapeutics, Inc. is (68.11 - 78.09), which suggest Halozyme Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Halozyme Therapeutics, Inc. is (65.45 - 74.09), which suggest Halozyme Therapeutics, Inc. is a Sell
* Halozyme Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.